Elysium

Elysium operates in the biotechnology industry, focusing on the development of supplements aimed at addressing cellular aging, brain health, immune support, and skin aging. The company offers an at-home biological age test, known as Index, which assesses aging through epigenetic markers. Elysium collaborates with prestigious academic institutions such as Oxford and Yale to enhance product development and research. Their products are distinguished by NSF Certification for Sport, which confirms adherence to stringent standards of quality and purity. Elysium is committed to scientific validation and conducts both ongoing and completed human clinical trials to verify the efficacy of their products. The company utilizes its proprietary epigenetic platform, APEX, to discover precise biomarkers based on DNA methylation data. Additionally, Elysium supports a wholesale program that enables medical professionals and businesses to distribute their products. They also offer a partner program where affiliates can earn commissions through referrals. Moreover, Elysium provides a flexible subscription service with monthly, semi-annual, and annual delivery options.